Login Register Cart 0
Generic placeholder image

Current Nutrition & Food Science

Editor-in-Chief

ISSN (Print): 1573-4013
ISSN (Online): 2212-3881

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Spices and Hypertension: An Insight for Researchers

Author(s): Kavyanjana R. Nair, Arya V.S, Kanthlal S.K. and Uma Devi P.*

Volume 18, Issue 3, 2022

Published on: 14 January, 2022

Page: [305 - 314] Pages: 10

DOI: 10.2174/1573401317666211122144827

Price: $65

Abstract

Hypertension is a global public health concern since it can lead to complications like stroke, heart disease, and kidney failure. These complications can add to a disability, increase healthcare costs, and can even result in mortality. In spite of the availability of a large number of anti-hypertensive drugs, the control of blood pressure is suboptimal in many patients. Spices have been used as flavouring agents and in treating diseases in folk medicine since they are considered to be rich sources of phytochemicals, especially polyphenols. Hence, during recent years, there has been renewed interest among researchers in exploring natural sources, especially spices, in an attempt to find cheaper alternatives with fewer side effects. Our aim is to review the relevant preclinical and clinical studies focused on the potential use of spices in the management of hypertension. Studies conducted on the most common spices, such as celery, cinnamon, cardamom, garlic, ginger, saffron, and turmeric, have been elaborated in this review. These spices may lower blood pressure via several possible mechanisms, including antioxidant effect, increase in nitric oxide production, reduction in calcium ion concentration, modulation of the renin-angiotensin pathway, etc.

Keywords: Blood pressure, cardamom, celery, cinnamon, garlic, ginger, saffron, turmeric.

« Previous Next »
Graphical Abstract

[1]
Fisher NDL, Curfman G. Hypertension - A public health challenge of global proportions. JAMA 2018; 320(17): 1757-9.
[http://dx.doi.org/10.1001/jama.2018.16760] [PMID: 30398584]
[2]
Chow CK, Gupta R. Blood pressure control: A challenge to global health systems. Lancet 2019; 394(10199): 613-5.
[http://dx.doi.org/10.1016/S0140-6736(19)31293-0] [PMID: 31327567]
[3]
Bolívar JJ. Essential hypertension: An approach to its etiology and neurogenic pathophysiology. Int J Hypertens 2013; 2013: 547809.
[http://dx.doi.org/10.1155/2013/547809] [PMID: 24386559]
[4]
Puddu P, Puddu GM, Zaca F, Muscari A. Endothelial dysfunction in hypertension. Acta Cardiol 2000; 55(4): 221-32.
[http://dx.doi.org/10.2143/AC.55.4.2005744] [PMID: 11041120]
[5]
Ferro CJ, Webb DJ. Endothelial dysfunction and hypertension. Drugs 1997; 53(1)(Suppl. 1): 30-41.
[http://dx.doi.org/10.2165/00003495-199700531-00006] [PMID: 9034753]
[6]
Loperena R, Harrison DG. Oxidative stress and hypertensive diseases. Med Clin North Am 2017; 101(1): 169-93.
[http://dx.doi.org/10.1016/j.mcna.2016.08.004] [PMID: 27884227]
[7]
Yim HE, Yoo KH. Renin-Angiotensin system - considerations for hypertension and kidney. Electrolyte Blood Press 2008; 6(1): 42-50.
[http://dx.doi.org/10.5049/EBP.2008.6.1.42] [PMID: 24459521]
[8]
Beevers G, Lip GYH, O’Brien E. ABC of hypertension: The pathophysiology of hypertension. BMJ 2001; 322(7291): 912-6.
[http://dx.doi.org/10.1136/bmj.322.7291.912] [PMID: 11302910]
[9]
Mahmood S, Shah KU, Khan TM, et al. Non-pharmacological management of hypertension: In the light of current research. Ir J Med Sci 2019; 188(2): 437-52.
[http://dx.doi.org/10.1007/s11845-018-1889-8] [PMID: 30136222]
[10]
Nguyen Q, Dominguez J, Nguyen L, Gullapalli N. Hypertension management: An update. Am Health Drug Benefits 2010; 3(1): 47-56.
[PMID: 25126308]
[11]
Park JB, Kario K, Wang JG. Systolic hypertension: An increasing clinical challenge in Asia. Hypertens Res 2015; 38(4): 227-36.
[http://dx.doi.org/10.1038/hr.2014.169] [PMID: 25503845]
[12]
Al Disi SS, Anwar MA, Eid AH. Anti-hypertensive herbs and their mechanisms of action: Part I. Front Pharmacol 2016; 6: 323.
[http://dx.doi.org/10.3389/fphar.2015.00323] [PMID: 26834637]
[13]
Anwar MA, Al Disi SS, Eid AH. Anti-hypertensive herbs and their mechanisms of action: Part II. Front Pharmacol 2016; 7: 50.
[http://dx.doi.org/10.3389/fphar.2016.00050] [PMID: 27014064]
[14]
Kochhar KP. Dietary spices in health and diseases: I. Indian J Physiol Pharmacol 2008; 52(2): 106-22.
[PMID: 19130854]
[15]
Kochhar KP. Dietary spices in health and diseases (II). Indian J Physiol Pharmacol 2008; 52(4): 327-54.
[PMID: 19585751]
[16]
Kunnumakkara AB, Sailo BL, Banik K, et al. Chronic diseases, inflammation, and spices: How are they linked? J Transl Med 2018; 16(1): 14.
[http://dx.doi.org/10.1186/s12967-018-1381-2] [PMID: 29370858]
[17]
Tsui PF, Lin CS, Ho LJ, Lai JH. Spices and atherosclerosis. Nutrients 2018; 10(11): 1724.
[http://dx.doi.org/10.3390/nu10111724] [PMID: 30423840]
[18]
Pereira ASP, Banegas-Luna AJ, Peña-García J, Pérez-Sánchez H, Apostolides Z. Evaluation of the anti-diabetic activity of some common herbs and spices: Providing new insights with inverse virtual screening. Molecules 2019; 24(22): 4030.
[http://dx.doi.org/10.3390/molecules24224030] [PMID: 31703341]
[19]
Zheng J, Zhou Y, Li Y, Xu DP, Li S, Li HB. Spices for prevention and treatment of cancers. Nutrients 2016; 8(8): 495.
[http://dx.doi.org/10.3390/nu8080495] [PMID: 27529277]
[20]
Vasanthi HR, Parameswari RP. Indian spices for healthy heart - an overview. Curr Cardiol Rev 2010; 6(4): 274-9.
[http://dx.doi.org/10.2174/157340310793566172] [PMID: 22043203]
[21]
Mirmosayyeb O, Tanhaei A, Sohrabi HR, et al. Possible role of common spices as a preventive and therapeutic agent for Alzheimer’s disease. Int J Prev Med 2017; 8: 5.
[http://dx.doi.org/10.4103/2008-7802.199640] [PMID: 28250905]
[22]
Kooti W, Daraei N. A review of the antioxidant activity of Celery (Apium graveolens L). J Evid Based Complementary Altern Med 2017; 22(4): 1029-34.
[http://dx.doi.org/10.1177/2156587217717415] [PMID: 28701046]
[23]
Al-Asmari AK, Athar MT, Kadasah SG. An updated phytopharmacological review on medicinal plant of Arab Region: Apium graveolens Linn. Pharmacogn Rev 2017; 11(21): 13-8.
[http://dx.doi.org/10.4103/phrev.phrev_35_16] [PMID: 28503047]
[24]
Fazal S, Ansari M, Singla RK, Khan S. Isolation of 3-n-butyl phthalide & sedanenolide from Apium graveolens Linn. Indo Glob J Pharm Sci 2012; 2(3): 258-61.
[25]
Moghadam MH, Imenshahidi M, Mohajeri SA. Antihypertensive effect of celery seed on rat blood pressure in chronic administration. J Med Food 2013; 16(6): 558-63.
[http://dx.doi.org/10.1089/jmf.2012.2664] [PMID: 23735001]
[26]
Dianat M, Veisi A, Ahangarpour A, Fathi Moghaddam H. The effect of hydro-alcoholic celery (Apium graveolens) leaf extract on cardiovascular parameters and lipid profile in animal model of hypertension induced by fructose. Avicenna J Phytomed 2015; 5(3): 203-9.
[PMID: 26101753]
[27]
Tashakori-Sabzevar F, Razavi BM, Imenshahidi M, et al. Evaluation of mechanism for antihypertensive and vasorelaxant effects of hexanic and hydroalcoholic extracts of celery seed in normotensive and hypertensive rats. Rev Bras Farmacogn 2016; 26(5): 619-26.
[http://dx.doi.org/10.1016/j.bjp.2016.05.012]
[28]
Tsi D, Tan B. Cardiovascular pharmacology of 3-n-butylphthalide in spontaneously hypertensive rats. Phytother Res 1997; 11(5): 576-82.
[http://dx.doi.org/10.1002/(SICI)1099-1573(199712)11:8<576:AID-PTR174>3.0.CO;2-7]
[29]
Madhavi D, Kagan D, Rao V, Murray MT. A pilot study to evaluate the antihypertensive effect of a Celery extract in mild to moderate hypertensive patients. Nat Med J 2013; 4(4): 7-9.
[30]
Jorge VG, Ángel JRL, Adrián TS, et al. Vasorelaxant activity of extracts obtained from Apium graveolens: Possible source for vasorelaxant molecules isolation with potential antihypertensive effect. Asian Pac J Trop Biomed 2013; 3(10): 776-9.
[http://dx.doi.org/10.1016/S2221-1691(13)60154-9] [PMID: 24075341]
[31]
Ko FN, Huang TF, Teng CM. Vasodilatory action mechanisms of apigenin isolated from Apium graveolens in rat thoracic aorta. Biochim Biophys Acta 1991; 1115(1): 69-74.
[http://dx.doi.org/10.1016/0304-4165(91)90013-7] [PMID: 1659912]
[32]
Rao PV, Gan SH. Cinnamon: A multifaceted medicinal plant. Evid Based Complement Alternat Med 2014; 2014: 642942.
[http://dx.doi.org/10.1155/2014/642942] [PMID: 24817901]
[33]
Ranasinghe P, Pigera S, Premakumara GAS, Galappaththy P, Constantine GR, Katulanda P. Medicinal properties of ‘true’ cinnamon (Cinnamomum zeylanicum): A systematic review. BMC Complement Altern Med 2013; 13: 275.
[http://dx.doi.org/10.1186/1472-6882-13-275] [PMID: 24148965]
[34]
Nyadjeu P, Dongmo A, Nguelefack TB, Kamanyi A. Antihypertensive and vasorelaxant effects of Cinnamomum zeylanicum stem bark aqueous extract in rats. J Complement Integr Med 2011; 8: 8.
[http://dx.doi.org/10.2202/1553-3840.1490] [PMID: 22754922]
[35]
Nyadjeu P, Nguelefack-Mbuyo EP, Atsamo AD, Nguelefack TB, Dongmo AB, Kamanyi A. Acute and chronic antihypertensive effects of Cinnamomum zeylanicum stem bark methanol extract in L-NAME-induced hypertensive rats. BMC Complement Altern Med 2013; 13: 27.
[http://dx.doi.org/10.1186/1472-6882-13-27] [PMID: 23368533]
[36]
Xue YL, Shi HX, Murad F, Bian K. Vasodilatory effects of cinnamaldehyde and its mechanism of action in the rat aorta. Vasc Health Risk Manag 2011; 7(1): 273-80.
[PMID: 21603596]
[37]
Anwar F, Abbas A, Alkharfy KM, Gilani A. Cardamom (Elettaria cardamomum Maton) Oil. In: Essential Oils in Food Preservation, Flavor and Safety. Elsevier 2016; pp. 295-301.
[http://dx.doi.org/10.1016/B978-0-12-416641-7.00033-X]
[38]
Sengupta A, Bhattacharjee S. Cardamom (Elettaria cardamomum) and its active constituent, 1,8-cineole. In: Molecular targets and therapeutic uses of spices- modern uses for ancient medicine. 2009; pp. 65-85.
[39]
Ashokkumar K, Murugan M, Dhanya MK, Warkentin TD. Botany, traditional uses, phytochemistry and biological activities of cardamom (Elettaria cardamomum (L.) Maton) - A critical review. J Ethnopharmacol 2020; 246: 112244.
[http://dx.doi.org/10.1016/j.jep.2019.112244] [PMID: 31541721]
[40]
Gilani AH, Jabeen Q, Khan AU, Shah AJ. Gut modulatory, blood pressure lowering, diuretic and sedative activities of cardamom. J Ethnopharmacol 2008; 115(3): 463-72.
[http://dx.doi.org/10.1016/j.jep.2007.10.015] [PMID: 18037596]
[41]
Verma SK, Jain V, Katewa SS. Blood pressure lowering, fibrinolysis enhancing and antioxidant activities of cardamom (Elettaria cardamomum). Indian J Biochem Biophys 2009; 46(6): 503-6.
[PMID: 20361714]
[42]
Bisht VK, Negi JS, Bhandari AK, Sundriyal RC. Amomum subulatum Roxb: Traditional, phytochemical and biological activities- An overview. Afr J Agric Res 2011; 6(24): 5386-90.
[http://dx.doi.org/10.5897/AJAR11.745]
[43]
Kanthlal SK, Joseph J, Paul B. M V, P UD. Antioxidant and vasorelaxant effects of aqueous extract of large cardamom in L-NAME induced hypertensive rats. Clin Exp Hypertens 2020; 42(7): 581-9.
[http://dx.doi.org/10.1080/10641963.2020.1739699] [PMID: 32202168]
[44]
Bayan L, Koulivand PH, Gorji A. Garlic: A review of potential therapeutic effects. Avicenna J Phytomed 2014; 4(1): 1-14.
[PMID: 25050296]
[45]
Adaki S, Adaki R, Shah K, Karagir A. Garlic: Review of literature. Indian J Cancer 2014; 51(4): 577-81.
[http://dx.doi.org/10.4103/0019-509X.175383] [PMID: 26842201]
[46]
Al-Qattan KK, Khan I, Alnaqeeb MA, Ali M. Mechanism of garlic (Allium sativum) induced reduction of hypertension in 2K-1C rats: A possible mediation of Na/H exchanger isoform-1. Prostaglandins Leukot Essent Fatty Acids 2003; 69(4): 217-22.
[http://dx.doi.org/10.1016/S0952-3278(03)00087-5] [PMID: 12907130]
[47]
Al-Qattan KK, Thomson M, Al-Mutawa’a S, Al-Hajeri D, Drobiova H, Ali M. Nitric oxide mediates the blood-pressure lowering effect of garlic in the rat two-kidney, one-clip model of hypertension. J Nutr 2006; 136(3)(Suppl.): 774S-6S.
[http://dx.doi.org/10.1093/jn/136.3.774S] [PMID: 16484561]
[48]
Vazquez-Prieto MA, González RE, Renna NF, Galmarini CR, Miatello RM. Aqueous garlic extracts prevent oxidative stress and vascular remodeling in an experimental model of metabolic syndrome. J Agric Food Chem 2010; 58(11): 6630-5.
[http://dx.doi.org/10.1021/jf1006819] [PMID: 20450156]
[49]
Nwokocha CR, Ozolua RI, Owu DU, Nwokocha MI, Ugwu AC. Antihypertensive properties of Allium sativum (garlic) on normotensive and two kidney one clip hypertensive rats. Niger J Physiol Sci 2011; 26(2): 213-8.
[PMID: 22547193]
[50]
Sharma DK, Manral A, Saini V, Singh A, Srinivasan BP, Tiwari M. Novel diallyldisulfide analogs ameliorate cardiovascular remodeling in rats with L-NAME-induced hypertension. Eur J Pharmacol 2012; 691(1-3): 198-208.
[http://dx.doi.org/10.1016/j.ejphar.2012.07.022] [PMID: 22819707]
[51]
Elkayam A, Peleg E, Grossman E, Shabtay Z, Sharabi Y. Effects of allicin on cardiovascular risk factors in spontaneously hypertensive rats. Isr Med Assoc J 2013; 15(3): 170-3.
[PMID: 23662381]
[52]
Ushijima M, Takashima M, Kunimura K, Kodera Y, Morihara N, Tamura K. Effects of S-1-propenylcysteine, a sulfur compound in aged garlic extract, on blood pressure and peripheral circulation in spontaneously hypertensive rats. J Pharm Pharmacol 2018; 70(4): 559-65.
[http://dx.doi.org/10.1111/jphp.12865] [PMID: 29380376]
[53]
Takashima M, Kanamori Y, Kodera Y, Morihara N, Tamura K. Aged garlic extract exerts endothelium-dependent vasorelaxant effect on rat aorta by increasing nitric oxide production. Phytomedicine 2017; 24: 56-61.
[http://dx.doi.org/10.1016/j.phymed.2016.11.016] [PMID: 28160862]
[54]
McMahon FG, Vargas R. Can garlic lower blood pressure? A pilot study. Pharmacotherapy 1993; 13(4): 406-7.
[PMID: 8361870]
[55]
Dhawan V, Jain S. Garlic supplementation prevents oxidative DNA damage in essential hypertension. Mol Cell Biochem 2005; 275(1-2): 85-94.
[http://dx.doi.org/10.1007/s11010-005-0824-2] [PMID: 16335787]
[56]
Duda G, Suliburska J, Pupek-Musialik D. Effects of short-term garlic supplementation on lipid metabolism and antioxidant status in hypertensive adults. Pharmacol Rep 2008; 60(2): 163-70.
[PMID: 18443377]
[57]
Ried K, Frank OR, Stocks NP. Aged garlic extract reduces blood pressure in hypertensives: A dose-response trial. Eur J Clin Nutr 2013; 67(1): 64-70.
[http://dx.doi.org/10.1038/ejcn.2012.178] [PMID: 23169470]
[58]
Nakasone Y, Nakamura Y, Yamamoto T, Yamaguchi H. Effect of a traditional Japanese garlic preparation on blood pressure in prehypertensive and mildly hypertensive adults. Exp Ther Med 2013; 5(2): 399-405.
[http://dx.doi.org/10.3892/etm.2012.819] [PMID: 23404465]
[59]
Ashraf R, Khan RA, Ashraf I, Qureshi AA. Effects of Allium sativum (garlic) on systolic and diastolic blood pressure in patients with essential hypertension. Pak J Pharm Sci 2013; 26(5): 859-63.
[PMID: 24035939]
[60]
Ried K, Travica N, Sali A. The effect of aged garlic extract on blood pressure and other cardiovascular risk factors in uncontrolled hypertensives: the AGE at Heart trial. Integr Blood Press Control 2016; 9: 9-21.
[http://dx.doi.org/10.2147/IBPC.S93335] [PMID: 26869811]
[61]
Ried K, Fakler P. Potential of garlic (Allium sativum) in lowering high blood pressure: Mechanisms of action and clinical relevance. Integr Blood Press Control 2014; 7: 71-82.
[http://dx.doi.org/10.2147/IBPC.S51434] [PMID: 25525386]
[62]
Mao QQ, Xu XY, Cao SY, et al. Bioactive compounds and bioactivities of Ginger (Zingiber officinale Roscoe). In: Foods (Basel, Switzerland). 2019; 8: p. (6)185.
[63]
Liu Y, Liu J, Zhang Y. Research progress on chemical constituents of Zingiber officinale Roscoe. BioMed Res Int 2019; 20195370823
[http://dx.doi.org/10.1155/2019/5370823] [PMID: 31930125]
[64]
Ghayur MN, Gilani AH. Ginger lowers blood pressure through blockade of voltage-dependent calcium channels. J Cardiovasc Pharmacol 2005; 45(1): 74-80.
[http://dx.doi.org/10.1097/00005344-200501000-00013] [PMID: 15613983]
[65]
Ghayur MN, Gilani AH, Afridi MB, Houghton PJ. Cardiovascular effects of ginger aqueous extract and its phenolic constituents are mediated through multiple pathways. Vascul Pharmacol 2005; 43(4): 234-41.
[http://dx.doi.org/10.1016/j.vph.2005.07.003] [PMID: 16157513]
[66]
Akinyemi AJ, Thomé GR, Morsch VM, et al. Dietary supplementation of ginger and turmeric rhizomes modulates platelets ectonucleotidase and adenosine deaminase activities in normotensive and hypertensive rats. Phytother Res 2016; 30(7): 1156-63.
[http://dx.doi.org/10.1002/ptr.5621] [PMID: 27151061]
[67]
Akinyemi AJ, Thomé GR, Morsch VM, et al. Effect of ginger and turmeric rhizomes on inflammatory cytokines levels and enzyme activities of cholinergic and purinergic systems in hypertensive rats. Planta Med 2016; 82(7): 612-20.
[http://dx.doi.org/10.1055/s-0042-102062] [PMID: 27002391]
[68]
Akinyemi AJ, Ademiluyi AO, Oboh G. Aqueous extracts of two varieties of ginger (Zingiber officinale) inhibit angiotensin I-converting enzyme, iron(II), and sodium nitroprusside-induced lipid peroxidation in the rat heart in vitro. J Med Food 2013; 16(7): 641-6.
[http://dx.doi.org/10.1089/jmf.2012.0022] [PMID: 23875904]
[69]
Bostan HB, Mehri S, Hosseinzadeh H. Toxicology effects of saffron and its constituents: A review. Iran J Basic Med Sci 2017; 20(2): 110-21.
[PMID: 28293386]
[70]
Gohari AR, Saeidnia S, Mahmoodabadi MK. An overview on saffron, phytochemicals, and medicinal properties. Pharmacogn Rev 2013; 7(13): 61-6.
[http://dx.doi.org/10.4103/0973-7847.112850] [PMID: 23922458]
[71]
Srivastava R, Ahmed H, Dixit RK. Dharamveer, Saraf SA. Crocus sativus L.: A comprehensive review. Pharmacogn Rev 2010; 4(8): 200-8.
[http://dx.doi.org/10.4103/0973-7847.70919] [PMID: 22228962]
[72]
Imenshahidi M, Razavi BM, Faal A, Gholampoor A, Mousavi SM, Hosseinzadeh H. The effect of chronic administration of saffron (Crocus sativus) stigma aqueous extract on systolic blood pressure in rats. Jundishapur J Nat Pharm Prod 2013; 8(4): 175-9.
[http://dx.doi.org/10.17795/jjnpp-12475] [PMID: 24624210]
[73]
Imenshahidi M, Razavi BM, Faal A, Gholampoor A, Mousavi SM, Hosseinzadeh H. The effect of chronic administration of safranal on systolic blood pressure in rats. Iran J Pharm Res 2015; 14(2): 585-90.
[PMID: 25901167]
[74]
Imenshahidi M, Razavi BM, Faal A, Gholampoor A, Mousavi SM, Hosseinzadeh H. Effects of chronic crocin treatment on desoxycorticosterone acetate (doca)-salt hypertensive rats. Iran J Basic Med Sci 2014; 17(1): 9-13.
[PMID: 24592301]
[75]
Nasiri Z, Sameni HR, Vakili A, Jarrahi M, Khorasani MZ. Dietary saffron reduced the blood pressure and prevented remodeling of the aorta in L-NAME-induced hypertensive rats. Iran J Basic Med Sci 2015; 18(11): 1143-6.
[PMID: 26949504]
[76]
Plangar AF, Anaeigoudari A. KhajaviRad A, Shafei MN. KhajaviRad, A.; Shafei, M.N. Beneficial cardiovascular effects of hydroalcoholic extract from Crocus sativus in hypertension induced by angiotensin II. J Pharmacopuncture 2019; 22(2): 95-101.
[PMID: 31338249]
[77]
Mancini A, Serrano-Díaz J, Nava E, et al. Crocetin, a carotenoid derived from saffron (Crocus sativus L.), improves acetylcholine-induced vascular relaxation in hypertension. J Vasc Res 2014; 51(5): 393-404.
[http://dx.doi.org/10.1159/000368930] [PMID: 25531977]
[78]
Sun W, Wang S, Zhao W, et al. Chemical constituents and biological research on plants in the genus Curcuma. Crit Rev Food Sci Nutr 2017; 57(7): 1451-523.
[http://dx.doi.org/10.1080/10408398.2016.1176554] [PMID: 27229295]
[79]
Zdrojewicz Z, Szyca M, Popowicz E, Michalik T, Śmieszniak B. Turmeric - not only spice. Pol Merkuriusz Lek 2017; 42(252): 227-30.
[PMID: 28662006]
[80]
Hewlings SJ, Kalman DS. Curcumin: A review of its’ effects on human health. Foods 2017; 6(10): E92.
[http://dx.doi.org/10.3390/foods6100092] [PMID: 29065496]
[81]
Goto H, Sasaki Y, Fushimi H, Shibahara N, Shimada Y, Komatsu K. Effect of curcuma herbs on vasomotion and hemorheology in spontaneously hypertensive rat. Am J Chin Med 2005; 33(3): 449-57.
[http://dx.doi.org/10.1142/S0192415X05003053] [PMID: 16047562]
[82]
Hlavačková L, Janegová A, Uličná O, Janega P, Cerná A, Babál P. Spice up the hypertension diet - curcumin and piperine prevent remodeling of aorta in experimental L-NAME induced hypertension. Nutr Metab (Lond) 2011; 8: 72.
[http://dx.doi.org/10.1186/1743-7075-8-72] [PMID: 22005253]
[83]
Nakmareong S, Kukongviriyapan U, Pakdeechote P, et al. Antioxidant and vascular protective effects of curcumin and tetrahydrocurcumin in rats with L-NAME-induced hypertension. Naunyn Schmiedebergs Arch Pharmacol 2011; 383(5): 519-29.
[http://dx.doi.org/10.1007/s00210-011-0624-z] [PMID: 21448566]
[84]
Boonla O, Kukongviriyapan U, Pakdeechote P, et al. Curcumin improves endothelial dysfunction and vascular remodeling in 2K-1C hypertensive rats by raising nitric oxide availability and reducing oxidative stress. Nitric Oxide 2014; 42: 44-53.
[http://dx.doi.org/10.1016/j.niox.2014.09.001] [PMID: 25194767]
[85]
Kukongviriyapan U, Pannangpetch P, Kukongviriyapan V, Donpunha W, Sompamit K, Surawattanawan P. Curcumin protects against cadmium-induced vascular dysfunction, hypertension and tissue cadmium accumulation in mice. Nutrients 2014; 6(3): 1194-208.
[http://dx.doi.org/10.3390/nu6031194] [PMID: 24662163]
[86]
Arya VS, Kanthlal SK, Prasanth BP, Vijayakumar M, Devi PU. Modulation of renin-angiotensin system by aqueous extract of large cardamom: In vitro and in silico studies. JBAPN 2020; 10: 373-8.
[87]
Akinyemi AJ, Thome GR, Morsch VM, Stefanello N. D, J.F.G.; Belló-Klein, A.; Oboh, G.; Schetinger, M.R.C. Effect of dietary supplementation of ginger and turmeric rhizomes on Angiotensin-1 Converting Enzyme (ACE) and arginase activities in L-NAME induced hypertensive rats. J Funct Foods 2015; 2015(17): 792-801.
[http://dx.doi.org/10.1016/j.jff.2015.06.011]
[88]
Li Y, Tian D, Zhu C, Ren L. Demethoxycurcumin preserves renovascular function by downregulating COX-2 expression in hypertension. Oxid Med Cell Longev 2016; 2016: 9045736.
[http://dx.doi.org/10.1155/2016/9045736] [PMID: 28105253]
[89]
Yao Y, Wang W, Li M, et al. Curcumin exerts its anti-hypertensive effect by down-regulating the AT1 receptor in vascular smooth muscle cells. Sci Rep 2016; 6: 25579.
[http://dx.doi.org/10.1038/srep25579] [PMID: 27146402]
[90]
Adaramoye OA, Anjos RM, Almeida MM, et al. Hypotensive and endothelium-independent vasorelaxant effects of methanolic extract from Curcuma longa L. in rats. J Ethnopharmacol 2009; 124(3): 457-62.
[http://dx.doi.org/10.1016/j.jep.2009.05.021] [PMID: 19481144]
[91]
Xu PH, Long Y, Dai F, Liu ZL. The relaxant effect of curcumin on porcine coronary arterial ring segments. Vascul Pharmacol 2007; 47(1): 25-30.
[http://dx.doi.org/10.1016/j.vph.2007.03.003] [PMID: 17459781]
[92]
Baradaran A, Nasri H, Rafieian-Kopaei M. Oxidative stress and hypertension: Possibility of hypertension therapy with antioxidants. J Res Med Sci 2014; 19(4): 358-67.
[PMID: 25097610]
[93]
Abrams WB. Pathophysiology of hypertension in older patients. Am J Med 1988; 85(3B): 7-13.
[http://dx.doi.org/10.1016/0002-9343(88)90343-9] [PMID: 3048095]

Rights & Permissions Print Cite
Article Metrics
10
1
© 2024 Bentham Science Publishers | Privacy Policy